ðïž ç¬ç« è «çãã¥ãŒã¹ â 2026.11.14
ç¬ç«ã®è «çã»ããé¢é£ãã¥ãŒã¹ïŒè«æ èš7ä»¶
ðïž è «çã»ããé¢é£ãã¥ãŒã¹ â 2026.11.14
æ¬æ¥ 7ä»¶
1. 𧬠ç ç©¶ã»ç§åŠ
ç¬ã®è «ç667äŸã®éºäŒåãè§£èªãããç¬ããã²ãã ã¢ãã©ã¹ããå ¬éââ40ç¬çš®ä»¥äžã»10çš®é¡ã®è «çã§4äž4,000è¶ ã®å€ç°ãããã®åå åè£éºäŒå39åãç¹å®(ããªã倧åŠã»ããScience)
ð 2026.11.12
ã€ã¿ãªã¢ã®ããªã倧åŠããããŒãã£å€§åŠãã«ã³ãã£ãªãŒãåœç«ããç ç©¶æãã¹ã€ã¹ã®ããªã³ãã©ãŒãè «çåŠç ç©¶æãªã©ã®ããŒã (Eugenio Mazzoneæ°ãLuca Aresuæ°ã)ã¯ãç¬ã®è «çã®éºäŒåããŸãšãããCanine Cancer Genome Atlas(CCGAãç¬ããã²ãã ã¢ãã©ã¹)ããScienceèªã«11æ12æ¥ä»ã§çºè¡šããŸããããããŸã§å€ãã®ç ç©¶ã«æ£ãã°ã£ãŠããããŒã¿ãçµ±äžããæ¹æ³ã§è§£æãçŽãããã®ã§ãåãç¬ã®è «ççµç¹ãšæ£åžžçµç¹ã®ãã¢667çµã®å šãšã¯ãœã³(éºäŒåã®ããã±ã質ãã€ããéšå)ã®ããŒã¿ãå«ã¿ãŸããäŒçŽã©ã»ã¹ã¿ã³ãã®å ±éã«ãããšã察象ã¯40以äžã®ç¬çš®ã骚èè «ãBçŽ°èæ§ãªã³ãè «ãä¹³è ºçãªã©ãå«ã10çš®é¡ã®è «çã§ãè «ç现èã§åŸããçããå€ç°ã¯4äž4,000ãè¶ ããŸãããè§£æã®çµæãããã®çºçãä¿ãããã©ã€ããŒéºäŒåãã®åè£ãšããŠ39åãç¹å®ãããTP53ãPIK3CAãPTENãSETD2ãMAP3K14ãFAT4ãªã©ã®å€ç°ãç¹°ãè¿ãã¿ãããŸããããŸããããéºäŒåMYCã®å¢å¹ ãPTENã®æ¬ 倱ãèŠã€ãã£ãŠããŸããããæå¶éºäŒåTP53ã®ç°åžžã¯7çš®é¡ã®ããã§ã¿ããããšãããŸãã
人ã®åãçš®é¡ã®ãããšæ¯ã¹ããšã骚èè «ã§ã¯DNAã®ä¿®åŸ©ã®ç°åžžãæè²äœã®äžå®å®ããBçŽ°èæ§ãªã³ãè «ã§ã¯çްèã®ä¿¡å·äŒéã®åè·¯ãä¹³è ºçã§ã¯å¢æ®ã調ç¯ããçµè·¯ã«å ±éç¹ããã£ãäžæ¹ãç¬ã«ç¹æã®ä»çµã¿ãããããšã瀺ãããŸãããããŒã¿ã¯å°çšãµã€ãã§å ¬éãããç ç©¶è ãèªç±ã«å©çšã§ããŸããAresuæ°ã¯ãä»åŸã®ç ç©¶ã®ãå ±éã®åºçºç¹ãã«ãªããšããŠããŸãããã ãã39åã®éºäŒåã®åœ¹å²ã¯ãããã確èªãå¿ èŠã§ããã®ã¢ãã©ã¹ã¯ãŸã åã ã®ç¬ã®æ²»çè¬ãéžã¶ããã®æ€èšŒæžã¿ã®éå ·ã§ã¯ãããŸãããæç¬ã«ããããäœèª¿ã®å€åãããã°æ©ãã«å蚺ããæ²»çã®éžæè¢ã¯è «çã®çš®é¡ããšã«ç£å»åž«ãšããçžè«ããŸãããã
ð https://pubmed.ncbi.nlm.nih.gov/43019437/
𧬠ç ç©¶ã»ç§åŠ
2. ð¥ å»çã»çŸç ã»äºé²
ç¬ã®ãªã³ãè «ãè¡æ¶²äžã®ãè «çDNAãã®å²åã§åçºãŸã§ã®æéãäºæž¬ã§ããå¯èœæ§ââ13é ã®äºåç ç©¶ã§ãè «çDNAãå€ã矀ã®ç¡å¢æªæéã¯77æ¥ãå°ãªã矀ã¯302æ¥(ãœãŠã«å€§åŠãVet Comp Oncol)
ð 2026.11.03
è¡æ¶²äžã«ã¯çްèããæŸåºãããDNA(ç¡çްèDNAãcfDNA)ãæµããŠãããããã®ç¬ã§ã¯ãã®äžéšãè «çã«ç±æ¥ããŸã(埪ç°è «çDNA)ãéåœã»ãœãŠã«å€§åŠç£å»åŠéšã®Kyoung-Won Seoæ°ããšäŒæ¥GenesisEgoã®ç ç©¶ããŒã ã¯ãå€äžå¿åãªã³ãè «ã®ç¬13é ãšå¥åº·ãªç¬24é ã®è¡æ¶²ããã²ãã å šäœãæµ ãèªããæµ ãå šã²ãã ã·ãŒã±ã³ã¹ããšããæ¯èŒçå®äŸ¡ãªæ¹æ³ã§èª¿ã¹ãäºåç ç©¶ããVeterinary and Comparative Oncologyèªã«11æ3æ¥ã«ãªã³ã©ã€ã³çºè¡šããŸããããªã³ãè «ã®ç¬ã®cfDNAæ¿åºŠã¯äžå€®å€3.18 ng/mLã§ãå¥åº·ãªç¬ã®0.25 ng/mLããææã«é«ãå€ã§ãã(p=0.004)ãcfDNAã®ç·éãšç æ°ãé²è¡ãããŸã§ã®æéãšã®é¢é£ã¯çµ±èšçã«ææã§ã¯ãããŸããã§ãã(p=0.055)ãäžæ¹ãcfDNAã®ãã¡è «çã«ç±æ¥ããå²å(è «çåç»)ãé«ã矀ã§ã¯ãç æ°ãé²è¡ãããŸã§ã®æé(ç¡å¢æªæé)ã®äžå€®å€ã77æ¥ã§ãäœã矀ã®302æ¥ããææã«çããªããŸãã(p=0.006)ãããéºäŒåMYCãå«ã13çªæè²äœã®å¢å ã3é ã§ã¿ãããããããè «çåç»ã®é«ã矀ã§ããã
è¡æ¶²ãæ¡ãã ãã§è «çã®éãæ§è³ªã調ã¹ãããªããããã€ãªãã·ãŒãã¯ã蚺æãæ²»ç广ã®ç¢ºèªãåçºã®æ©æçºèŠãžã®å¿çšãæåŸ ãããŠããŸããä»åã®çµæã¯ãè «çåç»ãäºåŸã®ç®å®ã«ãªãå¯èœæ§ã瀺ããã®ã§ããã13é ãšå°æ°ã®äºåç ç©¶ã§ãèè ãèªèº«ããã倧ããªéå£ã§ã®æ€èšŒãå¿ èŠãšããŠããŸããç¬ã®ãªã³ãè «ã¯ãããã®äžãããã®äžãã²ãã®è£ãªã©ã®ãªã³ãç¯ãè «ããŠæ°ã¥ãããšãå€ãç æ°ã§ããäœãè§Šã£ãŠããããè «ãã«æ°ã¥ãããæ©ãã«å蚺ããè¡æ¶²æ€æ»ãå«ãæ€æ»ãæ²»çã®èšç»ã¯ç£å»åž«ãšçžè«ããŸãããã
ð https://pubmed.ncbi.nlm.nih.gov/42974710/
ð¥ å»çã»çŸç ã»äºé²
3. 𧬠ç ç©¶ã»ç§åŠ
ç¬ã®ä¹³è ºè «çã®éºäŒåå€ç°ãçãmRNAã¯ã¯ãã³ãããŒã°ã«ã§å ç«åå¿ã確èªââBRCA2ãšp53ã®å€ç°ãæšçã«ãç¹°ãè¿ãæäžã§ãè¡æ¶²æ€æ»ã«å€§ããªç°åžžãªã(éåœã«ããªãã¯å€§åŠã»å¿ å倧åŠãVaccine)
ð 2026.11.12
éåœã«ããªãã¯å€§åŠã®Jae-Hwan Namæ°ãšå¿ å倧åŠç£å»åŠéšã®Sang-Myeong Leeæ°ãã®ç ç©¶ããŒã ã¯ãç¬ã®ä¹³è ºè «çã§èŠã€ããBRCA2ãšp53ã®éºäŒåå€ç°ãæšçã«ããmRNAã¯ã¯ãã³ã®ç ç©¶ããVaccineèªã«11æ12æ¥ã«ãªã³ã©ã€ã³çºè¡šããŸãããæ°åã³ããã¯ã¯ãã³ãšåãããmRNAãè質ããç²å(LNP)ã§å ãæ¹åŒã§ã3çš®é¡ã®mRNAãèšèšããããããçµã¿åããããã«ã¯ãã«ãã¯ã¯ãã³ãäœããŸããã人ã®å¹é€çްèã§ç®çã®ããã±ã質ãã€ããããããšã確ãããåŸãããŠã¹ã«æäžãããšãããå ç«ã®åãã瀺ãã€ã³ã¿ãŒãã§ãã³Î³(IFN-γ)ã匷ãåæ³ãããç¹ã«BRCA2ã®H143RãK801RãT1425Pãšãã3ã€ã®å€ç°ã«å¯Ÿããåå¿ã匷ãã¿ãããŸãããããã«å¥åº·ãªããŒã°ã«ã«ç¹°ãè¿ãæäžãããšãIFN-γã®ç£çãå¢ããäžæ¹ã§ãè¡æ¶²åŠçã»çååŠçæ€æ»ã«ææãªç°åžžã¯èªããããŸããã§ããã
ãã现èã«ã ãçããå€ç°ãç®å°ã«å ç«ãåãããã¯ã¯ãã³ã¯ã人ã®ããæ²»çã§ãç ç©¶ãé²ãã§ããåéã§ãç¬ã®ä¹³è ºè «çãžã®å¿çšãããããåºç€çãªææãšãããŸãããã ããä»å確ãããã®ã¯å ç«åå¿ãšå®å šæ§ã§ãè «çãå°ãããã广ã¯è©äŸ¡ãããŠããŸãããå®éã«ä¹³è ºè «çã®ããç¬ã§å¹æããããã¯ãä»åŸã®èšåºè©Šéšãå¿ èŠã§ããç¬ã®ä¹³è ºè «çã¯é¿åŠæè¡ãããŠããªãéã«å€ããããæ¥é ããèžãããè ¹ã«ãããŠã®ä¹³è ºãè§Šã£ãŠãããããªãã確èªããèŠã€ãããå°ãããã¡ã«ç£å»åž«ã«çžè«ããŸãããã
ð https://pubmed.ncbi.nlm.nih.gov/43019901/
𧬠ç ç©¶ã»ç§åŠ
4. ð¥ å»çã»çŸç ã»äºé²
ç«ã®ä¹³è ºçãè «çã®ãé質ããå€ãã»ã©çåæéãçãââéç«129é ã®è§£æã§ãé質ãç·ç¶åã®éãç¬ç«ããäºåŸå åã«(ãã«ã倧åŠã»ããVet Pathol)
ð 2026.11.02
ç«ã®ä¹³è ºè «çã¯å€ããæªæ§(ä¹³è ºç)ã§ãäºåŸãããæ£ç¢ºã«èŠç©ããææšãæ±ããããŠããŸãããã«ãã¬ã«ã®ãã«ã倧åŠICBASãäžå¿ã«ãç±³ãã³ã·ã«ããã¢å€§åŠç£å»åŠéšãåœå ã®è€æ°ã®åç©ç é¢ãåå ããç ç©¶ããŒã (Joana Rodrigues-Jesusæ°ãPatrÃcia Dias-Pereiraæ°ã)ã¯ãéç«129é ã®ä¹³è ºçã®çµç¹ã調ã¹ãç ç©¶ãVeterinary Pathologyèªã«11æ2æ¥ã«ãªã³ã©ã€ã³çºè¡šããŸããããã现èã®ãŸãããåãå²ããè «çé質ããã³ã©ãŒã²ã³(è åç·ç¶)ãããã«åå¿ããŠçããç·ç¶å(ç·ç¶åœ¢æããã¹ã¢ãã©ãžã¢)ã®éããç®èŠã«ããã¹ã³ã¢ãšç»åè§£æã§æ°å€åããŸãããå€ãã®æ€äœã§ã¯é質ã®å²åã¯50%æªæºã§ããããã³ã©ãŒã²ã³ã®ãã¡ç·ç¶åœ¢æãå ããæ¯çã¯å€§åã®çã§50%ãè¶ ããŠããŸãããé質ãå€ã矀ã«ã¯ãã¹ããŒãžIIIã®çäŸãçç现èã®æµžæœ€ã匷ãçäŸãå€ãã¿ãããŸãããé質ãç·ç¶åœ¢æãå€ãããšããã®æ¯çãé«ãããšã¯çåæéã®çããšé¢é£ããæ°å€ã§æž¬ã£ãææšã¯å€å€éè§£æã§ãç¬ç«ããäºåŸå åãšãªããŸããã
ãã现èãã®ãã®ã ãã§ãªãããã®ãŸããã®ç°å¢(è «ç埮å°ç°å¢)ãç«ã®ä¹³è ºçã®çµéã«åœ±é¿ããããšã瀺ãçµæã§ãéåžžã®ç çæšæ¬ããæž¬ãããããå°æ¥ã¯äºåŸã®å€å®ã«åœ¹ç«ã€å¯èœæ§ããããŸãããã ãåŸãåãã®ç ç©¶ã§ãæ¥åžžã®èšºæã§äœ¿ãã«ã¯æž¬å®æ¹æ³ã®æšæºåãå¥ã®éå£ã§ã®ç¢ºèªãå¿ èŠã§ããç«ã®ä¹³è ºã®ãããã¯å°ãããã¡ã«åé€ããã»ã©çµéãè¯ããšãããŠããŸãããè ¹ãæ«ã§ããšãã«ç±³ç²ã»ã©ã®ãããã§ãæ°ã¥ãããæ©ãã«å蚺ããæè¡ã®ç¯å²ãè¡åŸã®æ²»çã«ã€ããŠç£å»åž«ãšçžè«ããŸãããã
ð https://pubmed.ncbi.nlm.nih.gov/42969084/
ð¥ å»çã»çŸç ã»äºé²
5. 𧬠ç ç©¶ã»ç§åŠ
ç¬ã®BçŽ°èæ§ãªã³ãè «ã®æ°ããç ç©¶ã¢ãã«ãæ£è ç¬ç±æ¥ã®ç§»æ€ã¢ãã«3çš®ãšçŽ°èæ ª2çš®ãæš¹ç«ââ2019幎ã«äº¡ããªã£ãç ç©¶è ã®æ§æ³ãåŒãç¶ã(ã³ãŒãã«å€§åŠãCells)
ð 2026.10.30
ç±³ã³ãŒãã«å€§åŠç£å»åŠéšã¯10æ30æ¥ãç¬ã®BçŽ°èæ§ãªã³ãè «ã®æ°ããå®éšã¢ãã«ãéçºãããšçºè¡šããŸããããªã³ãè «ãšèšºæããã飌ãç¬ã®è «ççµç¹ãå ç«äžå šããŠã¹ã«ç§»æ€ãããæ£è ç±æ¥ç°çš®ç§»æ€(PDX)ã¢ãã«ã3çš®é¡ãšããã®ç§»æ€çµç¹ããäœã£ãå®å®ããçŽ°èæ ª2çš®é¡ã§ãå ã®ç¬ã®è «çã®éºäŒçã»çç©åŠçãªç¹åŸŽãããåçŸããŠãããšãããŸããææã¯9æ17æ¥ã«Cellsèªã«æ²èŒãããŸããããã®ç ç©¶ã¯ã人ã®è «çå ç§å»ããå倧åŠç£å»åŠéšã®åææã«è»¢ããç¬ã®ããæ£è ã®ç ç©¶ãéããŠç¬ãšäººã®äž¡æ¹ã®æ²»çæ¹åãããããŠããKristy Richardsæ°ãå§ãããã®ã§ãåæ°ã¯2019幎ã«äº¡ããªã£ãŠããŸããåæ°ã®ååã§è«æèè ã®äžäººã§ããååéºäŒåŠã®Robert Weissææã¯ãã¯ãªã¹ãã£ãããããšããŠããããšã®çã®ç¶ç¶ã ããšè¿°ã¹ãŠããŸãã
BçŽ°èæ§ãªã³ãè «ã¯ç¬ã§æãå€ãããã®äžã€ã§ãããæ°è¬ã詊ãããã®ä¿¡é Œã§ããå®éšã¢ãã«ã¯å°ãªãã®ãçŸç¶ã§ãããWeissæ°ã¯ãçŸåšã®æ²»çæ³ã§ã¯ç¬ã®ãªã³ãè «ã¯æ²»ããªãããšè©±ããŠãããæ°ããã¢ãã«ã¯æ²»çã®æšçæ¢ããèšåºè©Šéšåã®è¬ã®è©äŸ¡ã«åœ¹ç«ã€ãšæåŸ ãããŸããç¬ã®BçŽ°èæ§ãªã³ãè «ã¯äººã®éããžãã³ãªã³ãè «ãšãã䌌ãŠããããã人ã®å»çãžã®è²¢ç®ãèŠèŸŒãŸããŸãããã ãå®éšå®€ã§ã®ç ç©¶åºç€ã§ãããããã«æ°ããæ²»çã䜿ããããã«ãªãããã§ã¯ãããŸããããªã³ãè «ãšèšºæãããããçŸåšã®æšæºçãªååŠçæ³ã®èŠéããèšåºè©Šéšãžã®åå ã®å¯èœæ§ã«ã€ããŠãè «çãå°éãšããç£å»åž«ã«çžè«ããŠã¿ãŸãããã
𧬠ç ç©¶ã»ç§åŠ
6. ð¥ å»çã»çŸç ã»äºé²
ç¬ã®éªšã®ããã®çã¿ã«å€§éº»æåã®é£²ã¿è¬ãCannEpilããç±³FDAãæ¡ä»¶ä»ãæ¿èªãããããããã€ããŒãŠãŒã¹ãã«æå®ââ11æ19æ¥ã«FDAãšåè°ã2027幎ã®çºå£²ãç®æšã«(Endovia Health Sciences)
ð 2026.10.07
ç±³åœã®Endovia Health SciencesãšéçºããŒãããŒã®Lupvindol BioSciencesã¯10æ5æ¥ãç¬ã®éªšã®ãã(éªšè «ç)ã«ããçã¿ã«å¯Ÿããéçºäžã®é£²ã¿è¬ãCannEpilãã«ã€ããŠãç±³åœé£åå»è¬åå±(FDA)ã®åç©çšå»è¬åã»ã³ã¿ãŒããããã€ããŒãŠãŒã¹ã»ãã€ããŒã¹ããŒã·ãŒãº(MUMS)å¶åºŠã®ããã€ããŒãŠãŒã¹(察象ãå°ãªãçšé)ãã«è©²åœãããšã®å€æãåãããšçºè¡šããŸãã(dvm360ã10æ7æ¥ã«å ±é)ãCannEpilã¯ã«ã³ãããžãªãŒã«(CBD)ãšããã©ãããã«ã³ããããŒã«(THC)ãå«ãçµå£æ¶²å€ã§ãããã®æå®ã«ããã广ã®ãå®è³ªçãªèšŒæ ãã§ã¯ãªãã广ãåççã«æåŸ ã§ããããšãã瀺ãã°èªããããæ¡ä»¶ä»ãæ¿èªãããããããã«ãªããŸãããæ¡ä»¶ä»ãæ¿èªã¯1幎éæå¹ã§ãæ¬æ¿èªã«å¿ èŠãªããŒã¿ãéããéãæé·4幎ãŸã§æ¯å¹ŽæŽæ°ã§ããŸãã䞡瀟ã¯11æ19æ¥ã«FDAãšã®äºååè°ãäºå®ããŠãããæ¿èªãããã°2027幎ã®åç©çšã§ã®çºå£²ãããããšããŠããŸãã
ãã ããCannEpilã¯ãŸã æ¿èªãæ¡ä»¶ä»ãæ¿èªãåããŠããªãéçºäžã®è¬ã§ãçºè¡šã«ã¯ç¬ã§ã®å¹æãå®å šæ§ã®ããŒã¿ã¯ç€ºãããŠããŸããã骚èè «ãªã©ã®éªšã®ããã®çã¿ã¯åŒ·ããçæŽ»ã®è³ªã倧ããå·Šå³ãããããæ°ããé®çã®éžæè¢ãšããŠæ³šç®ãããŸãããªãæ¥æ¬ã§ã¯THCãå«ã補åã¯æ³åŸã§èŠå¶ãããŠãããåãè¬ãåœå ã§äœ¿ããããã«ãªãèŠéãã¯ãããŸãããåžè²©ã®CBD補åãèªå·±å€æã§äžããã®ã¯é¿ããæç¬ã®çã¿ã®ã±ã¢ã¯éã¹ããã€ãç³»æ¶çé®çè¬ãæŸå°ç·æ²»çãªã©ãå«ããŠç£å»åž«ãšçžè«ããŸãããã
ð¥ å»çã»çŸç ã»äºé²
7. 𧬠ç ç©¶ã»ç§åŠ
ãæ¥æ¬ãç¬ç«ã®ããçµç¹ããããªã«ã¬ãã€ãããäœããäžé ããšã«åãååæšçè¬ãæ¢ãââæ±äº¬å€§åŠã»æ±äº¬èŸ²å·¥å€§åŠãšåç©ç é¢ã°ã«ãŒããå ±åç ç©¶ãèšåºã§ã®æ€èšŒæ®µéãž(MiraiVets Partners)
ð 2026.10.23
åç©ç é¢ã°ã«ãŒãMiraiVets Partnersã®æ ªåŒäŒç€ŸANCHORSã¯10æ23æ¥ãæ±äº¬å€§åŠå€§åŠé¢èŸ²åŠçåœç§åŠç ç©¶ç§ã»éå±åç©å»çã»ã³ã¿ãŒããã³æ±äº¬èŸ²å·¥å€§åŠãšãç¬ç«ã®è «çã«å¯Ÿããåå¥åããååæšçè¬æ²»çã®éçºã«åããå ±åç ç©¶ãå§ãããšçºè¡šããŸãããäžé ããšã®ããçµç¹ãããäœã®å€ã§ç«äœçã«è²ã€ããèåšã®ãããªããªã«ã¬ãã€ãããäœãããã®åã®ããã«åãååæšçè¬ãéžã³åºããŠç§åŠçã«æ€èšŒãããšããåãçµã¿ã§ããææãªåè£ã¯ã倧åŠã®å«çå§å¡äŒã®æ¿èªãšé£Œãäž»ã®åæã®ããšã§èšåºç ç©¶ã«é²ãã广ãšå®å šæ§ã確ãããŸããç¹ã«ãæè¡ãæŸå°ç·ã ãã§ã¯å¯Ÿå¿ãé£ãã転移ãããããªã©ã«åããŠãèªå® ã§é£²ãŸããããçµå£ã®ååæšçè¬ã«éç¹ã眮ããŠããŸããæ±äº¬å€§åŠã®äžå·è²Žä¹ææãšå è€å€§è²Žç¹ä»»è¬åž«ãæ±äº¬èŸ²å·¥å€§åŠã®èŒäºéååææãåå ããANCHORSã¯15éœéåºçã®49ã®åç©ç é¢ãš1ã€ã®æ€æ»æœèšãããªãã°ã«ãŒãã®ãããã¯ãŒã¯ãéããŠãè «çãµã³ãã«ãèšåºæ å ±ã®æäŸãçäŸã®ç»é²ãæ ããŸãã
å瀟ã«ãããšãç ç©¶ã¯ãã§ã«èšåºã§ã®æ€èšŒæ®µéã«å ¥ã£ãŠãããææã¯æ¬§å·ç£å»è «çåŠäŒãæ¥æ¬ç£å»ããåŠäŒãªã©ã§çºè¡šãããŠããŸããäžæ¹ã§ãç¹å®ã®æ²»ç广ã¯ãŸã 蚌æãããŠããããå®çšåã®ææã瀺ãããŠããŸããã人ã®ããå»çã§ã¯æ£è ããšã®è¬éžã³ãé²ãã§ãããç¬ç«ã§ãæ²»çã®éžæè¢ãåºãã詊ã¿ãšããŠæåŸ ãããŸããæ²»çãé£ãããããšèšºæãããå Žåã¯ãæšæºçãªæ²»çã«å ããŠèšåºç ç©¶ãžã®åå ãšããéžæè¢ããããã©ããããæ åœã®ç£å»åž«ã«å°ããŠã¿ããšããã§ãããã
ð https://prtimes.jp/main/html/rd/p/000000004.000183725.html
𧬠ç ç©¶ã»ç§åŠ
ðïž ç¬ç«è «çãã¥ãŒã¹ | all-i-need-are-dogs.blog

ã³ã¡ã³ããã©ãã